Medtronic announces FDA approval of minimally invasive device to treat hypertension Medical Device Investing
Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Geography
Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center Psychedelics Investing
Medtronic: A Majority of Americans Are Optimistic That AI Will Improve Healthcare in 2024 Medical Device Investing
A majority of Americans are optimistic that AI will improve healthcare in 2024 Medical Device Investing
The Absence of an Overt Hepatic Encephalopathy -Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis Pharmaceutical Investing
CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy -Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis Pharmaceutical Investing
